Search Results - "HADDAD, TYLER"

Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival by Haddad, Tyler C., Zhao, Songzhu, Li, Mingjia, Patel, Sandip H., Johns, Andrew, Grogan, Madison, Lopez, Gabriella, Miah, Abdul, Wei, Lai, Tinoco, Gabriel, Riesenberg, Brian, Li, Zihai, Meara, Alexa, Bertino, Erin M., Kendra, Kari, Otterson, Gregory, Presley, Carolyn J., Owen, Dwight H.

“…Introduction Immune checkpoint inhibitors (ICI) are associated with unique immune-related adverse events (irAEs). Immune-related thrombocytopenia (irTCP) is an…”
Get full text

Acupuncture for Chemoradiation Therapy‐Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham‐Controlled Trial by Lu, Weidong, Wayne, Peter M., Davis, Roger B., Buring, Julie E., Li, Hailun, Macklin, Eric A., Lorch, Jochen H., Burke, Elaine, Haddad, Tyler C., Goguen, Laura A., Rosenthal, David S., Tishler, Roy B., Posner, Marshall R., Haddad, Robert I.

“…Introduction. Dysphagia is common in head and neck cancer patients after concurrent chemoradiation therapy (CRT). This study evaluated the feasibility of…”
Get full text

PRONE TO INJURY by HADDAD, TYLER, SYLVESTER, PATRICK, COTTEN, KYLE, KUENNEN, REBECCA, BHATT, NITIN Y, CHRISTMAN, JOHN W

Get full text

AN UNUSUAL CAUSE OF UNCONTROLLED ASTHMA SYMPTOMS by HADDAD, TYLER, SYLVESTER, PATRICK, LI, ZAIBO, BHATT, NITIN Y, WANG, JING G

Get full text

IMPROVING SLEEP IN THE MEDICAL INTENSIVE CARE UNIT: A QUALITY IMPROVEMENT INITIATIVE by MACDOWELL, SARAH M, HADDAD, TYLER, KOENIG, MICHAEL H, KRAMER, PATRICK J, NESBITT, NATHAN W, WODARCYK, ANDREW J, LEVI, AYAL, KREBER, LILY, CONROY, MEGAN

Get full text

Immune checkpoint inhibitor-related thrombocytopenia: Incidence, risk factors, and effect on overall survival by Haddad, Tyler, Zhao, Songzhu, Li, Mingjia, Patel, Sandip H., Johns, Andrew, Grogan, Madison, Lopez, Gabrielle, Miah, Abdul, Wei, Lai, Tinoco, Gabriel, Riesenberg, Brian P, Li, Zihai, Bertino, Erin Marie, Kendra, Kari Lynn, Otterson, Gregory Alan, Presley, Carolyn J, Owen, Dwight Hall

“…Abstract only e14549 Background: Immune checkpoint inhibitors (ICI) are a standard of care therapy for patients with many different cancers. ICI are generally…”
Get full text

Immune checkpoint inhibitor induced hepatitis: Risk factors, outcomes, and impact on survival by Miah, Abdul, Zhao, Songzhu, Patel, Sandip H., Johns, Andrew, Grogan, Madison, Li, Mingjia, Lopez, Gabrielle, Haddad, Tyler, Husain, Marium, Kendra, Kari Lynn, Otterson, Gregory Alan, Wei, Lai, Presley, Carolyn J, Owen, Dwight Hall

“…Abstract only e14525 Background: Immune checkpoint inhibitors (ICIs) have improved the survival of patients with multiple cancer types, however ICI treatment…”
Get full text

Proton pump inhibitor use (PPI) in patients treated with immune checkpoint inhibitors (ICI) for advanced cancer: Survival and prior therapy by Husain, Marium, Xu, Menglin, Patel, Sandipkumar, Johns, Andrew, Grogan, Madison, Li, Mingjia, Lopez, Gabrielle, Miah, Abdul, Hoyd, Rebecca, Liu, YunZhou, Muniak, Mitchell, Haddad, Tyler, Tinoco, Gabriel, Kendra, Kari Lynn, Otterson, Gregory Alan, Presley, Carolyn J, Spakowicz, Daniel, Owen, Dwight Hall

“…Abstract only 2633 Background: Emerging data suggest that concomitant medications (CM) influence response to ICI. CM impact the host microbiome which may…”
Get full text

In-Hospital Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement in Relation to Heart Failure Status in the United States: An Analysis of the National Inpatient Sample by Buda, Kevin, Patel, Hardikkumar, Haddad, Tyler, Patel, Rutu, Jha, Anil, Chakraborti, Abhishek, Mahmoud, Omar, Fangcheng, Wu, Krishnan, Anand

“…Transcatheter aortic valve replacement (TAVR) is an increasingly common method of valve replacement in patients that are not candidates for open heart surgery…”
Get full text

Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma by Chau, Nicole G, Li, Yvonne Y, Jo, Vickie Y, Rabinowits, Guilherme, Lorch, Jochen H, Tishler, Roy B, Margalit, Danielle N, Schoenfeld, Jonathan D, Annino, Don J, Goguen, Laura A, Thomas, Tom, Becker, Hailey, Haddad, Tyler, Krane, Jeffrey F, Lindeman, Neal I, Shapiro, Geoffrey I, Haddad, Robert I, Hammerman, Peter S

“…The clinical impact of next-generation sequencing (NGS) in patients with head and neck squamous cell carcinoma (HNSCC) has not been described. We aimed to…”
Get full text

Rationale and design of a randomized controlled clinical trial; Titration of Oxygen Levels (TOOL) during mechanical ventilation by Pannu, Sonal R., Haddad, Tyler, Exline, Matthew, Christman, John W., Horowitz, Jeffrey C., Peters, Jonathan, Brock, Guy, Diaz, Philip, Crouser, Elliott D.

“…Both hyperoxemia and hypoxemia are deleterious in critically ill patients. Targeted oxygenation is recommended to prevent both of these extremes, however this…”
Get full text

Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy by Guo, Yizhen, Wei, Lai, Patel, Sandip H., Lopez, Gabrielle, Grogan, Madison, Li, Mingjia, Haddad, Tyler, Johns, Andrew, Ganesan, Latha P., Yang, Yiping, Spakowicz, Daniel J., Shields, Peter G., He, Kai, Bertino, Erin M., Otterson, Gregory A., Carbone, David P., Presley, Carolyn, Kulp, Samuel K., Mace, Thomas A., Coss, Christopher C., Phelps, Mitch A., Owen, Dwight H.

“…•Hypoalbuminemia has broadly been viewed as a marker for unfavorable treatment response in advanced cancers, and poor health condition such as…”
Get full text

554. Does Protease Inhibitor (PI) Monotherapy Select Primary PI Resistance? by Saling, Christopher, Atallah, Liana, Haddad, Tyler, Learned, Brooke, Slim, Jihad

Get full text

Strategies to defeat ketamine-induced neonatal brain injury by Turner, C.P, Gutierrez, S, Liu, C, Miller, L, Chou, J, Finucane, B, Carnes, A, Kim, J, Shing, E, Haddad, T, Phillips, A

“…Abstract Studies using animal models have shown that general anesthetics such as ketamine trigger widespread and robust apoptosis in the infant rodent brain…”
Get full text

Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck by Harris, Ethan J., Huang, Julian, Carroll, Erin, Lowe, Alarice C., Chau, Nicole G., Rabinowits, Guilherme, Haddad, Robert, Hanna, Glenn J., Haddad, Tyler, Sanborn, Matthew, Kacew, Alec, Lorch, Jochen

“…Background Circulating tumors cells (CTCs) are considered an early step towards metastasis and have been linked to poor prognosis in several types of cancer…”
Get full text

Long-term effects of differential early rearing in rhesus macaques: Behavioral reactivity in adulthood by Corcoran, Christopher A., Pierre, Peter J., Haddad, Tyler, Bice, Christina, Suomi, Stephen J., Grant, Kathleen A., Friedman, David P., Bennett, Allyson J.

“…Adverse early experiences are associated with a range of deleterious health outcomes in humans, including higher risk for affective disorders. Studies using a…”
Get full text

Acupuncture for dysphagia after chemoradiation therapy in head and neck cancer: A randomized sham-controlled study by Lu, Weidong, Lorch, Jochen H., Wayne, Peter M, Davis, Roger B, Tishler, Roy B., Posner, Marshall R., Goguen, Laura A, Li, Hailun, Macklin, Eric, Burke, Elaine, Jaffa, Zachary, Dreyer, Nicholas J, Haddad, Tyler C, Buring, Julie E, Rosenthal, David S., Haddad, Robert I.

“…Abstract only 6058 Background: Dysphagia is a common side effect following chemoradiation (CRT) in pts with head and neck cancer (HNC). The purpose of this…”
Get full text

A phase II study of everolimus in patients with aggressive RAI refractory (RAIR) thyroid cancer (TC) by Lorch, Jochen H., Busaidy, Naifa, Ruan, Daniel T, Janne, Pasi A., Limaye, Sewanti Atul, Wirth, Lori J., Barletta, Justine A., Rabinowits, Guilherme, Garraway, Levi A., Van Allen, Eliezer Mendel, Wagle, Nikhil, Hanna, Glenn J., Misiukiewicz, Krzysztof, Suda, Margaret, Haddad, Tyler C, Devine, Catherine E, Williams, Amy, Warsi, Ghulam, Posner, Marshall R., Haddad, Robert I.

“…Abstract only 6023 Background: We present results of an open label phase II study of the mTOR inhibitor Everolimus in patients (pts) with RAIR TC. Methods: Pts…”
Get full text